Lung‐Chih Li

1.2k total citations
44 papers, 910 citations indexed

About

Lung‐Chih Li is a scholar working on Surgery, Nephrology and Molecular Biology. According to data from OpenAlex, Lung‐Chih Li has authored 44 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 17 papers in Nephrology and 11 papers in Molecular Biology. Recurrent topics in Lung‐Chih Li's work include Dialysis and Renal Disease Management (9 papers), Eosinophilic Esophagitis (5 papers) and Parathyroid Disorders and Treatments (5 papers). Lung‐Chih Li is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Eosinophilic Esophagitis (5 papers) and Parathyroid Disorders and Treatments (5 papers). Lung‐Chih Li collaborates with scholars based in Taiwan, China and United Kingdom. Lung‐Chih Li's co-authors include Chien‐Te Lee, Wen‐Chin Lee, Wei‐Yu Chen, Jenq‐Lin Yang, Jin‐Bor Chen, Hwee‐Yeong Ng, Yueh‐Ting Lee, Tzu‐Hsien Tsai, Zac Varghese and Xiong Z. Ruan and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Lung‐Chih Li

43 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lung‐Chih Li Taiwan 17 269 256 205 185 139 44 910
Yu Ho Lee South Korea 16 336 1.2× 204 0.8× 277 1.4× 112 0.6× 143 1.0× 57 892
Hequn Zou China 19 255 0.9× 186 0.7× 201 1.0× 78 0.4× 145 1.0× 51 792
Bryan R. Conway United Kingdom 20 422 1.6× 171 0.7× 451 2.2× 116 0.6× 138 1.0× 41 1.2k
Hanyu Zhu China 19 266 1.0× 119 0.5× 410 2.0× 82 0.4× 110 0.8× 90 982
Tomás P. Griffin Ireland 17 168 0.6× 214 0.8× 134 0.7× 99 0.5× 213 1.5× 52 853
Catalina Martín-Cleary Spain 18 251 0.9× 154 0.6× 489 2.4× 131 0.7× 109 0.8× 29 995
Susumu Ookawara Japan 19 221 0.8× 308 1.2× 394 1.9× 97 0.5× 60 0.4× 127 1.1k
Heyuan Ding China 14 297 1.1× 141 0.6× 120 0.6× 124 0.7× 177 1.3× 36 818
Fenfen Peng China 18 457 1.7× 191 0.7× 410 2.0× 84 0.5× 65 0.5× 73 1.1k

Countries citing papers authored by Lung‐Chih Li

Since Specialization
Citations

This map shows the geographic impact of Lung‐Chih Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lung‐Chih Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lung‐Chih Li more than expected).

Fields of papers citing papers by Lung‐Chih Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lung‐Chih Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lung‐Chih Li. The network helps show where Lung‐Chih Li may publish in the future.

Co-authorship network of co-authors of Lung‐Chih Li

This figure shows the co-authorship network connecting the top 25 collaborators of Lung‐Chih Li. A scholar is included among the top collaborators of Lung‐Chih Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lung‐Chih Li. Lung‐Chih Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tain, You‐Lin, et al.. (2024). Gestational Exposure to Maternal Systemic Glucocorticoids and Childhood Risk of CKD. American Journal of Kidney Diseases. 84(2). 215–223.e1. 4 indexed citations
2.
Tain, You‐Lin, et al.. (2024). Gestational Exposure to Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Childhood. JAMA Pediatrics. 179(2). 171–171. 4 indexed citations
3.
Hsu, Chien‐Ning, et al.. (2023). Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women. Pharmaceuticals. 16(2). 222–222. 2 indexed citations
4.
Chien, Shao‐Ju, et al.. (2023). Guideline-Adherent Hypertension in Children and Adolescents: A Multi-Institutional Database Analysis from Taiwan. Journal of Clinical Medicine. 12(13). 4367–4367. 2 indexed citations
5.
6.
Li, Lung‐Chih, et al.. (2023). Cardiovascular diseases morbidity and mortality among children, adolescents and young adults with dialysis therapy. Frontiers in Public Health. 11. 1142414–1142414. 2 indexed citations
7.
Chen, Hsin–Wei, et al.. (2022). Comparative Adverse Kidney Outcomes in Women Receiving Raloxifene and Denosumab in a Real-World Setting. Biomedicines. 10(7). 1494–1494. 2 indexed citations
8.
Li, Lung‐Chih, et al.. (2022). Trajectory of low-density lipoprotein cholesterol in patients with chronic kidney disease and its association with cardiovascular disease. Frontiers in Cardiovascular Medicine. 9. 887915–887915. 3 indexed citations
9.
Chen, Jin‐Bor, Chiung‐Chih Chang, Sin‐Hua Moi, & Lung‐Chih Li. (2022). A Profile of Nanoparticle-Based Plasma Neurodegenerative Biomarkers for Cognitive Function Among Patients Undergoing Hemodialysis. International Journal of General Medicine. Volume 15. 6115–6125. 4 indexed citations
10.
Lee, Yueh‐Ting, et al.. (2021). Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting. Frontiers in Pharmacology. 12. 781379–781379. 10 indexed citations
11.
Chen, Wei‐Yu, Tzu‐Hsien Tsai, Alan Chuan‐Ying Lai, et al.. (2021). Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Theranostics. 11(6). 2594–2611. 36 indexed citations
12.
Chen, Jin‐Bor, Chiung‐Chih Chang, Lung‐Chih Li, et al.. (2020). Mutual Interaction of Clinical Factors and Specific microRNAs to Predict Mild Cognitive Impairment in Patients Receiving Hemodialysis. Cells. 9(10). 2303–2303. 6 indexed citations
13.
Hsu, Chien‐Ning, et al.. (2019). Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients. Journal of Clinical Medicine. 8(7). 932–932. 12 indexed citations
14.
Lee, Ing‐Kit, Zih‐Syuan Yang, Hwee‐Yeong Ng, et al.. (2019). Impaired production of immune mediators in dengue virus type 2-infected mononuclear cells of adults with end stage renal disease. Scientific Reports. 9(1). 19783–19783. 4 indexed citations
15.
Chen, Wei‐Yu, et al.. (2018). IL-33/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury. Experimental & Molecular Medicine. 50(4). 1–11. 13 indexed citations
16.
Chen, Wei‐Yu, Tzu‐Hsien Tsai, Jenq‐Lin Yang, & Lung‐Chih Li. (2018). Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases. Cellular Physiology and Biochemistry. 49(1). 349–358. 57 indexed citations
17.
Lee, Wen‐Chin, Ben‐Chung Cheng, Lung‐Chih Li, et al.. (2016). Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines. BioMed Research International. 2016. 1–7. 5 indexed citations
18.
Cheng, Ben‐Chung, et al.. (2016). Serum Alkaline Phosphatase Levels are Not Associated with Increased Death Risk in Prevalent Hemodialysis Patients: 5-Year Experience in a Single Hemodialysis Center. Kidney & Blood Pressure Research. 41(4). 498–506. 9 indexed citations
19.
Lee, Wen‐Chin, Lung‐Chih Li, Jin‐Bor Chen, & Hsueh‐Wei Chang. (2015). Indoxyl Sulfate‐Induced Oxidative Stress, Mitochondrial Dysfunction, and Impaired Biogenesis Are Partly Protected by Vitamin C and N‐Acetylcysteine. The Scientific World JOURNAL. 2015(1). 620826–620826. 43 indexed citations
20.
Zhou, Chao, Han Lei, Yaxi Chen, et al.. (2013). Enhanced SCAP Glycosylation by Inflammation Induces Macrophage Foam Cell Formation. PLoS ONE. 8(10). e75650–e75650. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Ho Lee Breakdown of academic impact, for papers by Hequn Zou Breakdown of academic impact, for papers by Bryan R. Conway Breakdown of academic impact, for papers by Hanyu Zhu Breakdown of academic impact, for papers by Tomás P. Griffin Breakdown of academic impact, for papers by Catalina Martín-Cleary Breakdown of academic impact, for papers by Susumu Ookawara Breakdown of academic impact, for papers by Heyuan Ding Breakdown of academic impact, for papers by Fenfen Peng
Rankless by CCL
2026